COVID-19 countermeasures: Evidence for an intent to harm
Alexandra Latypova, also known as Sasha, is a former Pharmaceutical R&D Executive who has owned and managed several contract research organizations. She retired from the industry but launched an independent investigation into the COVID-19 pandemic response due to concerns about irregularities, cover-up, and apparent fraud committed by the U.S. Government, Department of Defense, and Department…